CSF1 and memory impairment: M-CSF was able to prevent the apparition of memory impairment, which occurred normally at 6 months, as revealed by the number of trials (10.4 ± 1.4 vs. 17.4 ± 1.7 for APPSwe/PS1 mice; p < 0.05) (Figures 8A–C).